• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

SetSet Launches Clinician-Approved Platform to Deliver Safe Psychedelic Experiences for Women

by Jasmine Pennic 09/20/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– SetSet, the pioneering platform connecting consumers and medical providers for safe microdosing, has officially launched. 

–  The innovative platform is specifically designed to empower women in navigating psychedelic experiences through community support, therapist-created curriculum, and access to trained practitioners.

Addressing Mental Health Disparities

The launch of SetSet addresses a critical need, as women are disproportionately affected by mental health challenges like anxiety and depression. Many are turning to psychedelics such as psilocybin and ketamine as potential alternatives to conventional pharmaceutical treatments.

A Growing Need for Safe and Informed Psychedelic Use

Despite the rising popularity of psychedelics, a vast majority of users lack access to scientifically backed education and integration support. This is particularly true for women, who stand to benefit significantly from psychedelics but are underrepresented in clinical trials. The high cost of licensed psychedelic support further limits access, pushing many to rely on unreliable online information and potentially increasing the risk of adverse outcomes.

SetSet: Empowering Women in Psychedelic Exploration

SetSet’s platform offers women access to licensed therapists and medical providers who provide expert guidance on setting, dosage, contraindications, and after-care. It also fosters a safe and supportive community where users can share experiences and connect with others on similar journeys. All this is available starting at an affordable $47/month.

Ambitious Growth Plans

SetSet has set ambitious goals for the coming year, aiming to onboard 10,000 founding members, including individuals and healthcare professionals in the U.S. and Canada. To support this expansion, the company is seeking $2M in angel investment from mission-aligned backers. The funds will be used to expand the team, provider network, educational offerings, and proprietary technology.

“Women aren’t adequately supported in the current mental healthcare system and need a safe space to explore alternative options like psychedelics. I’ve seen the lack of education and support firsthand, which is why I created SetSet,” says April Pride, SetSet CEO and Founder, who brings nearly a decade of experience in the cannabis space with three successful exits.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |